Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
A prospective, open-label, single-arm, multi-center, phase II exploratory study to evaluate the efficacy and safety of poziotinib (NOV120101) in patients with HER2-positive metastatic breast cancer who have received at least two prior HER2-directed regimens
- Authors
- Park, YH[Park, Y-H]; Jung, KH[Jung, K. H.]; Sohn, JH[Sohn, J. H.]; Lee, KS[Lee, K. S.]; Lee, KH[Lee, K. H.]; Kim, JH[Kim, J-H]; Kim, JY[Kim, J-Y]; Jung, J[Jung, J.]; Han, H[Han, H.]; Park, WY[Park, W-Y]; Im, SA[Im, S-A]
- Issue Date
- 15-Feb-2016
- Publisher
- AMER ASSOC CANCER RESEARCH
- Citation
- CANCER RESEARCH, v.76
- Indexed
- SCIE
SCOPUS
- Journal Title
- CANCER RESEARCH
- Volume
- 76
- ISSN
- 0008-5472
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.